Recombinant Oncolytic Vaccinia Virus (Bionoxx)

N/A

Report date: 2026/04/10 20:01:49

Base Information

Drug NameRecombinant Oncolytic Vaccinia Virus (Bionoxx)
Drug Alias NameOTS-412
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBionoxx Inc
China Registration ClassN/A

Develop Information

Active CompaniesBionoxx Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A